Pharmacogenomics of platinum-based chemotherapy in NSCLC

By Hildebrandt Michelle AT   Gu Jian   Wu Xifeng  

Expert Opinion on Drug Metabolism and Toxicology, Vol. 5, Iss. 7, 2009-07 ,pp. : 745-755

Informa Healthcare

Access to resources Recommend Favorite

Overcoming platinum resistance in ovarian carcinoma

By Matsuo Koji   Lin Yvonne G   Roman Lynda D   Sood Anil K  

Expert Opinion on Investigational Drugs, Vol. 19, Iss. 11, 2010-11 ,pp. : 1339-1354

Informa Healthcare

Access to resources Recommend Favorite

Pharmacogenomics in lung cancer: an analysis of DNA repair gene expression in patients treated with platinum-based chemotherapy

By García-Campelo Rosario   Alonso-Curbera Guillermo   Antón Aparicio LM   Rosell Rafael  

Expert Opinion on Pharmacotherapy, Vol. 6, Iss. 12, 2005-10 ,pp. : 2015-2026

Informa Healthcare

Access to resources Recommend Favorite

Safety profile of platinum-based chemotherapy in the treatment of advanced non-small cell lung cancer in elderly patients

By Rossi Antonio   Maione Paolo   Gridelli Cesare  

Expert Opinion on Drug Safety, Vol. 4, Iss. 6, 2005-11 ,pp. : 1051-1067

Informa Healthcare

Access to resources Recommend Favorite

Exome Sequencing of Ovarian Cancer Patients to Identify Variants Predictive of Sensitivity to Platinum-based Chemotherapy

By  

Current Pharmacogenomics and Personalized Medicine (Formerly Current Pharmacogenomics), Vol. 14, Iss. 2, 2017-04 ,pp. : 124-133

Bentham Science Publishers

Access to resources Recommend Favorite